Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 195

1.

Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes.

Gallagher EJ, Zelenko Z, Tobin-Hess A, Werner U, Tennagels N, LeRoith D.

Diabetologia. 2017 Apr;60(4):758-759. doi: 10.1007/s00125-017-4225-3. No abstract available.

PMID:
28229179
2.

The sword of Damocles for the splenectomised: death by OPSI.

Blumentrath CG, Ewald N, Petridou J, Werner U, Hogan B.

Ger Med Sci. 2016 Aug 29;14:Doc10. doi: 10.3205/000237. eCollection 2016.

3.

Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes.

Gallagher EJ, Zelenko Z, Tobin-Hess A, Werner U, Tennagels N, LeRoith D.

Diabetologia. 2016 Sep;59(9):2018-25. doi: 10.1007/s00125-016-4000-x. Epub 2016 May 30. Erratum in: Diabetologia. 2017 Feb 23;:. Diabetologia. 2017 Apr;60(4):758-759.

PMID:
27241182
4.

Oral delivery of diabetes peptides - Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context.

Lakkireddy HR, Urmann M, Besenius M, Werner U, Haack T, Brun P, Alié J, Illel B, Hortala L, Vogel R, Bazile D.

Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):196-222. doi: 10.1016/j.addr.2016.02.011. Epub 2016 Mar 8. Review.

PMID:
26964477
5.

Validation of "laboratory-supported" criteria for functional (psychogenic) tremor.

Schwingenschuh P, Saifee TA, Katschnig-Winter P, Macerollo A, Koegl-Wallner M, Culea V, Ghadery C, Hofer E, Pendl T, Seiler S, Werner U, Franthal S, Maurits NM, Tijssen MA, Schmidt R, Rothwell JC, Bhatia KP, Edwards MJ.

Mov Disord. 2016 Apr;31(4):555-62. doi: 10.1002/mds.26525. Epub 2016 Feb 16.

PMID:
26879346
6.

Corrigendum: Epidermal growth factor receptor subunit locations determined in hydrated cells with environmental scanning electron microscopy.

Peckys DB, Baudoin JP, Eder M, Werner U, de Jonge N.

Sci Rep. 2015 Aug 3;5:12661. doi: 10.1038/srep12661. No abstract available.

7.

Methane and nitrous oxide emissions from a subtropical coastal embayment (Moreton Bay, Australia).

Musenze RS, Werner U, Grinham A, Udy J, Yuan Z.

J Environ Sci (China). 2015 Mar 1;29:82-96. doi: 10.1016/j.jes.2014.06.049. Epub 2014 Dec 24.

PMID:
25766016
8.

Sulfide and methane production in sewer sediments.

Liu Y, Ni BJ, Ganigué R, Werner U, Sharma KR, Yuan Z.

Water Res. 2015 Mar 1;70:350-9. doi: 10.1016/j.watres.2014.12.019. Epub 2014 Dec 17.

PMID:
25543244
9.

Assessing the spatial and temporal variability of diffusive methane and nitrous oxide emissions from subtropical freshwater reservoirs.

Musenze RS, Grinham A, Werner U, Gale D, Sturm K, Udy J, Yuan Z.

Environ Sci Technol. 2014 Dec 16;48(24):14499-507. doi: 10.1021/es505324h. Epub 2014 Dec 4.

PMID:
25409278
10.

Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue.

Werner U, Korn M, Schmidt R, Wendrich TM, Tennagels N.

Arch Physiol Biochem. 2014 Oct;120(4):158-65. doi: 10.3109/13813455.2014.950589. Epub 2014 Aug 21.

11.

Exciting: a full-potential all-electron package implementing density-functional theory and many-body perturbation theory.

Gulans A, Kontur S, Meisenbichler C, Nabok D, Pavone P, Rigamonti S, Sagmeister S, Werner U, Draxl C.

J Phys Condens Matter. 2014 Sep 10;26(36):363202. doi: 10.1088/0953-8984/26/36/363202. Epub 2014 Aug 19.

PMID:
25135665
12.

The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus.

Christensen M, Miossec P, Larsen BD, Werner U, Knop FK.

Expert Opin Drug Discov. 2014 Oct;9(10):1223-51. doi: 10.1517/17460441.2014.942638. Epub 2014 Aug 14. Review.

PMID:
25119443
13.

Tremor associated with Klinefelter syndrome--a case series and review of the literature.

Koegl-Wallner M, Katschnig-Winter P, Pendl T, Melisch B, Trummer M, Holl E, Werner U, Schmidt R, Schwingenschuh P.

Parkinsonism Relat Disord. 2014 Mar;20(3):323-7. doi: 10.1016/j.parkreldis.2013.11.010. Epub 2013 Dec 4. Review.

PMID:
24345964
14.

Methane and nitrous oxide emissions from a subtropical estuary (the Brisbane River estuary, Australia).

Musenze RS, Werner U, Grinham A, Udy J, Yuan Z.

Sci Total Environ. 2014 Feb 15;472:719-29. doi: 10.1016/j.scitotenv.2013.11.085. Epub 2013 Dec 10.

PMID:
24333994
15.

Effect of the glucagon-like peptide-1 receptor agonist lixisenatide on postprandial hepatic glucose metabolism in the conscious dog.

Moore MC, Werner U, Smith MS, Farmer TD, Cherrington AD.

Am J Physiol Endocrinol Metab. 2013 Dec;305(12):E1473-82. doi: 10.1152/ajpendo.00354.2013. Epub 2013 Oct 22.

16.

Epidermal growth factor receptor subunit locations determined in hydrated cells with environmental scanning electron microscopy.

Peckys DB, Baudoin JP, Eder M, Werner U, de Jonge N.

Sci Rep. 2013;3:2626. doi: 10.1038/srep02626. Erratum in: Sci Rep. 2015;5:12661.

17.

Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying--preclinical evidence.

Werner U.

J Diabetes Complications. 2014 Jan-Feb;28(1):110-4. doi: 10.1016/j.jdiacomp.2013.06.003. Epub 2013 Aug 28. Review.

18.

Insulin receptor phosphorylation by endogenous insulin or the insulin analog AspB10 promotes mammary tumor growth independent of the IGF-I receptor.

Gallagher EJ, Alikhani N, Tobin-Hess A, Blank J, Buffin NJ, Zelenko Z, Tennagels N, Werner U, LeRoith D.

Diabetes. 2013 Oct;62(10):3553-60. doi: 10.2337/db13-0249. Epub 2013 Jul 8.

19.

Differences in metabolic and mitogenic signallingof insulin glargine and AspB10 human insulin in rats [corrected].

Tennagels N, Welte S, Hofmann M, Brenk P, Schmidt R, Werner U.

Diabetologia. 2013 Aug;56(8):1826-34. doi: 10.1007/s00125-013-2923-z. Epub 2013 May 8. Erratum in: Diabetologia. 2014 Jan;57(1):263.

20.

Cardioprotective effects of lixisenatide in rat myocardial ischemia-reperfusion injury studies.

Wohlfart P, Linz W, Hübschle T, Linz D, Huber J, Hess S, Crowther D, Werner U, Ruetten H.

J Transl Med. 2013 Mar 28;11:84. doi: 10.1186/1479-5876-11-84.

Supplemental Content

Loading ...
Support Center